Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Metastatic Prostate Cancer That is Hormone-Independent: Evaluation of the Role of Chemotherapy on the Quality of Life of Patients. Phase II Study

NCT00003682 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00003682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Metastatic Prostate Cancer That is Hormone-Independent: Evaluation of the Role of Chemotherapy on the Quality of Life of Patients. Phase II Study
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 1998
Completion date
March 31, 2001
Enrollment
160 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer